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Abstract
Background
Malaria-endemic countries in sub-Saharan Africa are shifting from the presumptive
approach that is based on clinical judgement (CJ) to the test-based approach that is based
on confirmation through test with rapid diagnostic tests (RDT). It has been suggested that
the loss of the prophylactic effect of presumptive-administered ACT in children who do not
have malaria will result in increase in their risk of malaria and anaemia.
Methods and Findings
We undertook a cluster-randomized controlled trial to compare the effects of the presump-
tive approach using clinical judgment (CJ-arm) and the test-based approach using RDTs
(RDT-arm in a high-transmission setting in Ghana. A total of 3046 eligible children (1527 in
the RDT arm and 1519 in the CJ- arm) living around 32 health centres were enrolled. Nearly
half were female (48.7%) and 47.8% were below the age of 12 months as at enrolment.
Over 24-months, the incidence of all episodes of malaria following the first febrile illness
was 0.64 (95% CI 0.49–0.82) and 0.76 (0.63–0.93) per child per year in the RDT and CJ
arms respectively (adjusted rate ratio 1.13 (0.82–1.55). After the first episode of febrile ill-
ness, the incidence of severe anaemia was the same in both arms (0.11 per child per year)
and that of moderate anaemia was 0.16 (0.13–0.21) vs. 0.17 (0.14–0.21) per child year
respectively. The incidence of severe febrile illness was 0.15 (0.09, 0.24) in the RDT arm
compared to 0.17 (0.11, 0.28) per child per year respectively. The proportion of fever cases
receiving ACT was lower in the RDT arm (72% vs 81%; p = 0.02).
Conclusion
The test-based approach to the management of malaria did not increase the incidence of
malaria or anaemia among under-five children in this setting.
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Introduction
Although appreciable progress has been made in the control of malaria the disease remains an
important cause of morbidity and mortality in endemic countries in sub-Saharan Africa.[1,2]
Diagnosis has been a major challenge confronting effective clinical management of malaria.
The approach to malaria diagnosis has important implications for its effective prevention and
control. [3,4]
The two main approaches to the diagnosis of malaria are the presumptive and test-based
approaches. The presumptive (or clinical judgement-based) approach relies solely on present-
ing signs and symptoms to establish diagnosis while the test-based approach relies on parasito-
logical confirmation. For many years, the presumptive approach has been used across all age
groups and transmission settings. The approach was justified on the basis of the following: (1)
A high proportion of febrile illnesses in high-endemic settings was due to malaria, and the dis-
ease took a rapidly-deteriorating course in under-five children. Treatment therefore needed to
be initiated promptly. (2) Microscopy which was the only practical means for confirming the
diagnosis of malaria was technically complex and not available in areas that had the highest
burden of the disease. (3) The first-line drugs used to treat malaria before the introduction of
artemisinin-combination treatment (chloroquine and sulphadoxine-pyrimethamine) were
safe, effective and inexpensive.[5,6] The presumptive approach formed the basis of the man-
agement of malaria within the Integrated Management of Childhood Illnesses (IMCI). [7]
In early 2010, WHO issued revised guidelines for the management of malaria that called for
a shift from the presumptive to the test-based approach, across all transmission settings and in
all age groups. The justifications for the shift include: (1) Substantial decline in the levels of
malaria transmission in many countries including some areas that were previously high-trans-
mission settings; (2) Availability of reliable malaria rapid diagnostic tests (mRDTs) for use as a
point-of-care device; (3) Artemisinin-based combination treatments (ACTs), the current drugs
of choice for treatment of malaria, are relatively expensive.[8] Given the emergence of delayed
parasite clearance with the use of ACT in endemic countries in Southeast Asia, there is an
urgent need to reduce unwarranted use of ACTs, and the chances of resistance development.
[9,10,11] The use of test to differentiate between malaria and non-malaria cases is also expected
to lead to improved attention to the proper management of non-malarial febrile illnesses. It is
also expected to lead to substantial reduction in ACT cost to national programmes.
Those who opposed the shift to this approach argued that reported reductions in the trans-
mission of malaria were not widespread enough to justify a change in the treatment guidelines.
They also hypothesized that reduction in ACT use will remove the protective effect of intermit-
tent preventive treatment (IPT)[12] in children who test negative. This concern is based on the
fact that in many settings in malaria-endemic sub-Saharan Africa, children aged less than 2
year suffer at least four episodes of febrile illnesses each year. About half of these episodes are
non-malarial[13] and therefore restricting ACT to RDT positive cases alone could substantially
reduce the number of children receiving ACT for a febrile episode. The preventive benefit of
IPT has been demonstrated in studies across different transmission settings in sub-Saharan
Africa[12,13,14] and the reduction in ACT use in this regard could imply a loss of the opportu-
nistic prophylactic benefit it would offers.[15] This could lead to an increased risk of malaria in
children who present with non-malarial febrile illnesses. The trial that demonstrated the
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efficacy of IPT used non-ACT medications and the protective effect, where established largely
attributed to the non-artemisinin partner drug with a longer half-life.
Currently there are very few diagnostic tools that can be applied to determine the aetiology
of non-malarial febrile illnesses at point-of-care, and on that basis decide when to prescribe
antibiotics. In the absence of improved diagnostics tools for the management of these illnesses,
test-based management of malaria could (conceptually-considered) also lead to substantial
increase in the inappropriate use of antibiotics to manage such cases.
We report here on a cluster-randomized, controlled trial we undertook a comparison of the
effects of test-based (intervention) versus presumptive (control) approaches to the manage-
ment of malaria in rural Ghana. We hypothesized that test-based management of malaria will
lead to reduction in ACT prescription and use. This will result in an increase in the incidence
of malaria and anaemia, as well as in the prescription of antibiotics. The trial was registered in
the online clinical trials registry as NCT00832754.
Methods
The protocol for the study was approved by the Ethical Review Committees of KHRC, the
Ghana Health Service (GHS), and the London School of Hygiene and Tropical Medicine
(LSHTM). Signed (thumb printed if unable to read or write in English) informed consent was
obtained from each caregiver prior to enrolment of the child. A Data Safety Monitoring Board
(DSMB) periodically reviewed safety parameters and incidence of malaria and anaemia. The
DSMB also approved the final analysis plan.
Study area
The study was conducted in six districts in Ghana between February 2009 and July 2012. The
districts lie within the forest-savannah transition zone which is considered to have perennially-
high malaria transmission. According to data from routine health services, malaria is the lead-
ing cause of morbidity and mortality in the districts. In 2003–4, the Entomological Inoculation
Rate (EIR) was estimated at 231–269 infective bites per person per year. [16] At the time of ini-
tiating the study health centres in the districts were using the presumptive approach in the
management of fevers. The antimalarials used in the management of fevers were the nation-
ally-approved first line ACTs: artesunate-amodiaquine, artemether-lumefantrine and dihy-
droartemisinin-piperaquine. In a cross-sectional study conducted during the course of the
trial, the majority of caregivers preferred the test-based approach to the clinical judgement
approach to managing fevers in under-five children. Caregivers considered the test-based
approach to represent an improvement in health service delivery.[17]
Selection and randomisation of health centres
The unit of randomisation was health centres. Thirty two health centres were stratified by dis-
tricts, ranked by the number of Diptheria-Pertussis-Tetanus1 (DPT1) vaccinations given in the
facility in the preceding year and paired according to the rank within each district. Within each
pair of health facilities one was allocated randomly to implement test-based (RDT-arm) man-
agement of malaria, while the other health facility within the pair was allocated to implement
the clinical judgement (CJ arm) approach. This was done using STATA software.
Enrolment and data collection
Between January 2010 and May 2010, we enumerated all households that were located within
2km radius of the selected health centres and enrolled one hundred children per health facility
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who met the following criteria: (1) age<24 months; (2) caregiver indicated they used the index
health centre as first point of call whenever the child was unwell; (3) caregiver was willing to
give informed consent for the child to be enrolled in the study.
We enrolled children living closest to the selected health centres and extended outwards cir-
cumferentially till the target of 100 children was achieved. Enrolled children were given a study
identification card with a unique identification code. We recruited thirty-two research field-
workers and trained them on Good Clinical Practice (GCP) and the standard operating proce-
dures of the study. We also trained them on how to take blood from finger prick to perform
malaria RDTs, how to use of the Hemocue™ to measure haemoglobin levels, and how to pre-
pare blood smears for microscopy. One fieldworker was stationed at each health centre. Each
district had a research field supervisor who paid daily visits to each of the health centres to
review work, collect completed study forms and blood samples.
All health workers in the participating facilities who took care of sick children were given
refresher training in the management of febrile illnesses according to IMCI guidelines. This
training was conducted just before commencement of the study and repeated every 4–6
months throughout the period of the study. Clinicians in all the participating health facilities
were taken through the correct use and interpretation of RDT. This training relied on the find-
ings of an earlier study into the accuracy of an HRP-2 RDT in the study area by the research
team. In that study, a high rate of false-positive RDT results due to antigen persistence was
observed.[18] We used this locally-generated evidence to teach clinicians to enquire about
recent malaria treatment whenever they were confronted with positive RDT results. It was
expected that clinicians from the control facilities would still find the knowledge useful to
apply in the care of non-study patients. In the course of the trial any new health workers posted
to a health centre were also taken through the protocol of the study and correct use of RDTs.
Each blood slide in the study was read independently by two expert microscopists at the ref-
erence laboratory at the Kintampo Health Research Centre (KHRC). Discrepancies were
resolved through a third reading by a third microscopist.
Intervention and control
In health facilities that were randomised to the test-based (intervention) approach, all enrolled
children who reported with fever were tested with mRDT and received an ACT only when the
test was positive. The mRDTs used in the study were procured from the Ghana National
Malaria Control Program. Two brands of mRDTs procured through the Ghana National
Malaria Control Programme, CareStart™ and First Response™, were used throughout the period
of the study. They were also treated for any concurrent illnesses according to IMCI guidelines.
In health facilities that were randomised to the clinical judgement (control) approach,
enrolled children who presented with fever were not tested for malaria. The treatment for
malaria in these facilities was presumptive and based on presenting clinical symptoms and
signs. The treatment of all other ailments were based on the IMCI guidelines.
The fieldworkers stationed in each (intervention and control) health facility helped to
ensure compliance with the protocol by reminding attending clinicians about the protocol of
the study, as applicable to the particular health centre. This was reinforced during the 4–6
monthly training sessions that were held for health workers in both intervention and control
facilities.
Surveillance for febrile illnesses
All caregivers of children enrolled into the study were advised to bring their sick children to
the health centre. To overcome the possible effect of financial barrier, the project paid to have
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all the children enrolled under the Ghana National Health Insurance Scheme. Whenever a
study child presented with axillary temperature of 37.5°C or above, or reported fever in the pre-
ceding 72 hours, the fieldworker took blood samples for blood smear microscopy and used the
Hemocue1 to determine haemoglobin level. The result of the haemoglobin test was made
available to the attending health worker together with the result of mRDT if the health centre
was an intervention facility. In facilities in the CJ arm, only haemoglobin test and blood smear
microscopy were done. The results of the haemoglobin test were also made available to the
attending health worker to guide clinical management.
As part of active surveillance, field supervisors visited study children at least once every two
months and asked the caretakers about any febrile illnesses that may have occurred in the
period in between visits. The field supervisors completed morbidity questionnaires during each
visit. This process of surveillance was instituted to ensure that all febrile episodes that could
have been reported to local pharmacies and chemical shops was captured. If a child was unwell
at the time of the home visit or reported having had fever in the preceding 72 hours, the field
supervisor issued a referral note and advised the caregiver to send the child to the study health
centre.
Sample size
The primary endpoint was incidence of malaria during the 24 months of follow-up after the
first episode of febrile illness. It was estimated that to assess the effect of test-based manage-
ment of malaria on the incidence of malaria in children under 48 months of age would require
30 clusters (15 per arm) and 200 person-years at risk (PYAR) per cluster. This was based on
the following expectations: (1) Incidence of malaria in the CJ arm would be 0.8 episode/ 1 per
child per year (the rate observed in a group of<24 month old children in Navrongo, Ghana
[13]; (2) the coefficient of variation in the incidence of malaria between clusters will be 0.18;
(3) The study would have 80% power at 95% significance level to detect a 20% difference in the
incidence of malaria between the two comparison groups.
As the total number of children living around some of the selected health facilities was
<100 an additional pair of health centres was selected randomly in order to reach the required
number of children. Although mortality was measured in the study, it was assumed a priori
that the number of deaths would not be sufficient to detect any significant difference between
the two arms.
Data management and analysis
Data were double-entered using FoxPro version 9. The analysis was conducted using STATA
version 12. Intention-to-treat analysis was performed using all enrolled children while per pro-
tocol analysis was applied to children who adhered to correct assessment and treatment crite-
ria. Person-time in the study for each child was calculated using dates on which children were
seen at home visits or at a health facility. If a child was not seen for more than 3 months, the
person-time was censored for this period until they were seen again. Malaria was defined as the
presence of fever and a positive blood smear microscopy result. Fever was considered to be
severe when it was associated with one of more of the IMCI danger signs of lethargy or drowsi-
ness, vomiting everything, refusing all food including breastfeeding and convulsions.
The sociodemographic characteristics of children in the two arms of the enrolled cohort
were measured and compared using Pearson’s chi-square corrected for clusters. Similarly fever
episodes and corresponding blood test results and ACT prescriptions were compared. A multi-
level Poisson model assuming unstructured covariance was used to estimate the incidence of
malaria over the 24-month period to account for repeat episodes of malaria within a child, and
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clustering by heath facility. For the incidence of first or only episodes of malaria, moderate
anaemia (haemoglobin between 5-8g/dL), severe anaemia (haemoglobin less than 5g/dL) and
severe febrile illness, after the first febrile episode, a random effects Poisson model was applied,
adjusting for age, socio economic status, and ITN use. In this report we present the survival
analysis (in addition to the Poisson models) to show events over the entire follow-up period
and also to offer opportunity for cross-reference with other studies.
Results
Potentially eligible children were enumerated between April 2010 and May 2010. Those who
were available were consent and enrolled in June 2010 and followed up to June 2012. A total of
3046 eligible children (1527 in the RDT arm and 1519 in the CJ arm) were enrolled around the
32 health centres. (Fig 1) Nearly half of the study children were female (48.7%). Just about half
47.8% were also below the age of 12 months at the time of enrolment.
As part of active surveillance, 46,395 home visits were made over the 24-month follow-up
period. The median number of home visits was 15 per child in both arms. 23.1% of children
were referred to a health centre at least once following a home visit because they had fever or
history of fever in the preceding 72 hours. The number of cases referred after homes visits were
similar in both arms of the study (347 versus 357, p = 0.83). (Table 1) The mean number of
passive health facility visits was 4.1 in the test-based arm and 4.3 in the CJ arm (p = 0.73). Two
hundred and seventy five (9.0%) study children never visited the health centre throughout the
follow-up period but they were regularly seen at home visits.
The median time to first episode of fever was similar between the two arms (105 days in
RDT versus 111 days in CJ arm). At their first visit to the health facility, 713 (29.1%) children
had haemoglobin less than 8gm/dL. The median level of haemoglobin at the first contact was
similar in both arms of the study (9.0 versus 9.2 gm/dL). The number of episodes of febrile ill-
ness per child over the 2 year study period was also similar between the two groups (3.7 vs 3.8
per child). In the RDT arm, 98.2% of febrile episodes seen at the health centres were tested with
RDT and 72.3% were RDT positive. The sensitivity, specificity and positive predictive value for
RDT use in the RDT-arm were 95%, 64% and 53% respectively. As a deviation from the study
protocol, 8 out of 5799 (0.14%) cases that presented to CJ-arm facilities had RDT performed.
(Table 2).
Intention-to-treat
Malaria. The incidence of all episodes (first or repeat) of malaria was 0.99 per child per
year (95% CI 0.78, 1.27) in the RDT arm compared to 1.05 per child per year (95% CI 0.87,
1.29) in the CJ arm. There was no significant difference in the incidence of all episodes of
malaria following the first episode of febrile illness (adjusted rate Ratio 1.13, 0.82–1.55)
(Table 3). The survival time to malaria after the first episode of a febrile illness was similar for
both the first or only episode of malaria and for all episodes of malaria (Fig 2). Within the
RDT arm, the mean time to an episode of malaria following treatment with ACT for a febrile
illness was 309 days compared to 252 days in those who did not receive an ACT for febrile ill-
ness, p = 0.009. The mean time to an episode of malaria for children who were RDT negative
and therefore did not receive ACT but whose blood smear results were positive is 194 days.
Severe febrile illness. A total of 1200 episodes of severe febrile illness occurred among 760
children during the period of follow-up. The incidence of severe febrile illness after a first epi-
sode was 0.15 (0.09–0.24) per child per year in the RDT arm compared with 0.17 (0.11–0.28)
among children in the CJ arm (p = 0.78). The incidence of severe febrile illnesses was higher in
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children aged below 12 months of age at the time of enrolment (0.18 per child per year; 0.13–
0.24) compared to those12 months of age (0.14 per child per year; 0.10–0.21). (Table 3)
Anaemia. The incidence of moderate or severe anaemia in children following an episode
of febrile illness was not significantly different between the two groups; 0.16 (0.13–0.21) vs.
0.17 (0.14–0.21) per child year and 0.11 (0.09–0.14) vs. 0.11 (0.95–0.15) per child year respec-
tively. The adjusted rate ratios were 1.04 (0.76–1.44) and 1.04 (0.76–1.41) for moderate and
severe anaemia respectively (Table 3).
Fig 1. Trial Profile.
doi:10.1371/journal.pone.0152960.g001
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Deaths. There were 21 (1.4%) deaths in the CJ arm compared with 15(1.0%) deaths in the
RDT-arm. The difference was not statistically significant (p = 0.31).
ACT and antibiotic prescription. The proportion of fever cases that got treated with
ACT was lower in the RDT arm compared to the CJ arm (72.3 vs. 80.8%; p = 0.02). Although
the number of blood smears that were positive was similar in both arms (50.3% versus 53.3%;
p = 0.61), the number of children who were blood smear positive but did not receive ACT was
significantly higher in the CJ arm than in the RDT arm (12.5% versus 6.5%; p = 0.04)
(Table 2).
The proportion of children receiving an antibiotic for a febrile episode was slightly lower in
the RDT arm than in the CJ arm this difference was not statistically significant (48% vs 54%;
p = 0.23). In the RDT arm the proportion of children receiving an antibiotic was higher among
RDT negative compared to RDT positive children (85% vs. 44%; p< .0001). The proportion of
children receiving a combination of an ACT and antibiotic was lower in the RDT arm but this
Table 1. Characteristics and comparability of children enrolled into the two arms of the study.
Test-based approach (RDT) Clinical judgement (CJ) P-value
Total 1527* 1519*
Age < 12months 766 (50.2%) 691 (45.5%) 0.16
12months 761 (49.8%) 828 (54.5%)
Sex Male 779 (51.1%) 782 (51.5%) 0.75
Female 747 (49.0%) 736 (48.5%)
Highest educational level of mother None 425 (28.1%) 450 (29.7%) 0.75
Primary 360 (23.7%) 341 (22.5%)
Secondary 715 (47.2%) 717 (47.3%)
Tertiary 15 (1.0%) 7 (0.5%)
Highest educational level of father None 345 (24.1%) 326 (22.0%) 0.72
Primary 261 (18.2%) 267 (18.0%)
Secondary 752 (52.6%) 835 (56.2%)
Tertiary 70.0 (4.9%) 57 (3.8%)
Ownership of bednet Yes 1135 (74.4%) 1200 (79.0%) 0.26
No 391 (25.6%) 319 (21.0%)
Socioeconomic status Most poor 311 (20.5%) 296 (19.5%) 0.67
Poorer 267 (17.6%) 340 (22.4%)
Poor 290 (19.1%) 318 (21.0%)
Less poor 325 (21.4%) 278 (18.4%)
Least poor 324 (21.4%) 283 (18.7%)
Immunization status Incomplete 716 (52.3%) 704 (50.2%) 0.79
Complete 653 (47.7%) 698 (49.8%)
Number of home visits made <15 458 (30.0%) 632 (41.6%) 0.46
15 1069 (57.8%) 887 (58.4%)
Weight on 1st visit <10kg 681 (49.9%) 641 (45.8%) 0.29
10kg 684 (51.1%) 760 (54.3%)
Time to 1st fever <131 days 608 (48.1%) 661 (51.6%) 0.39
131 days 655 (51.9%) 620 (48.4%)
Haemoglobin level at 1st visit <8gm/dl 365 (30.2%) 329 (28.0%) 0.39
8-11gm/dl 711 (58.8%) 794 (58.3%)
>11gm/dl 133 (11.0%) 202 (13.7%)
*Missing data in some variables account for numbers that are less than the total number of enrolled children.
doi:10.1371/journal.pone.0152960.t001
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was not statistically significant (32% for RDT arm vs. 41% in the CJ arm; p = 0.13). However
the proportion of children who received only antibiotics was significantly higher in the CJ arm
compared to the RDT arm (15.6% versus 22.9% p = 0.02). (Table 3)
Per protocol analysis
The results of the per protocol analysis of all outcomes were similar to the intention to treat
analysis (Data are not shown)
Discussion
This study has used a cluster-randomised design to compare the effects of test-based manage-
ment of malaria to the presumptive approach that had been practised for several decades. This
study achieved a near-perfect provider adherence to test results or to clinical judgement. The
observed incidence of 1.09 episodes per child per year in the CJ arm was higher than the
assumed incidence of 0.8 episode per child year used in the sample size estimation. Thus the
study was adequately powered to detect the anticipated 20% difference in the incidence of
malaria. Given that adherence to the protocol was very good, the diagnosis of malaria was con-
firmed by microscopy and the study was adequately powered, we believe this study provides
substantially robust evidence on the likely effects of test-based management of malaria in high
transmission settings.
Previous studies that examined the effects of test-based management of malaria had been
limited by the lack of appropriate comparator cohort[18,19,20], relatively smaller sample sizes
[18], inadequate length of child follow-up [21], a failure to randomize the allocation of partici-
pants [18,19,20,21] and inadequate adherence to RDT-negative results. [22] These limitations
should be considered when comparing the findings from those studies with the current study.
Table 2. RDT and blood smear result and ACT prescription.
Test-based
approach
(RDT)
Clinical
judgement
(CJ)
P-value
n % n %
Total febrile episodes 5673 49.5 5799 50.5
Febrile episodes tested with RDT 5573 98.2 8 0.14 <0.001
Febrile Episodes receiving ACT 4100 72.3 4686 80.8 0.02
Febrile Episodes receiving antibiotics 3111 54.8 3260 56.2 0.78
RDT positive episodes 4112 73.8 4 50.0 0.06
RDT positive episodes receiving ACT 4023 97.8 4 100 0.80
RDT positive episodes receiving antibiotics 1813 44.1 2 50.0 0.75
RDT negative episodes 1461 26.2 4 50.0 0.06
RDT negative episodes receiving ACT 54 3.7 1 25.0 0.05
RDT negative episodes receiving antibiotics 1246 85.3 3 75.0 0.58
Blood Smear Positive episode 2795* 49.3 2914 50.3 0.85
Blood smear positive and RDT positive 2640 94.7 2 50.0 0.0001
Blood smear positive episode but did not receive ACT 181 6.5 360 12.4 0.04
Blood smear negative episodes that received ACT 1486 51.6 2132 73.9 <0.001
Blood smear negative episodes that received antibiotics 1926 66.9 1781 61.7 0.30
Blood smear positive episodes received antibiotics 1185 42.4 1479 50.8 0.16
* RDT results were missing for 8 blood smear positive episodes.
doi:10.1371/journal.pone.0152960.t002
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There is however fair consistency across these studies to suggest that denying ACT to RDT-
negative children does not lead to adverse treatment outcomes. In a study in two transmission
settings in Tanzania involving 1000 children with a febrile illness, no significant adverse treat-
ment outcomes were observed over a 7 day post-treatment follow up period among those chil-
dren who were RDT negative and were not given an antimalarial drug. [19] Although it was
demonstrated in a high-transmission setting in Ghana that the course of clinical recovery for
RDT-negative children differed markedly from RDT-positive cases, overall treatment out-
comes were comparable and no serious adverse effects were observed in children who were
treated using the test-based approach.[18] Similar results were found in a low transmission set-
ting in Kampala, Uganda where a representative sample of 601 children between one and ten
years of age were followed up over a period of 18 months [21] and in north-eastern Tanzania
where the test-based approach was adopted to treat 965 children enrolled over a period of one
year.[20] In contrast a study in a high-transmission setting in Burkina Faso found that the
effects of the test-based approach also depended on the ability of clinicians to identify and treat
children with non-malarial febrile illnesses who are coincidentally test positive.[22] For the
purpose of assessing the effects of test-based versus clinical judgement-based management of
Table 3. Incidence of health outcomes in RDT versus CJ arms.
Test-based approach (RDT) Clinical Judgement (CJ) Rate Ratio
(95%CI)
P-
value
Number of children 1527 1519
Number of
episodes
Incidence rate
(95%CI)
Number of
episodes
Incidence rate
(95%CI)
Incidence of malaria
All episodes Crude‡ 2645 0.99 (0.78,1.27) 2806 1.05 (0.87,1.29) 1.09
(0.81,1.48)
0.53
Adjusted† 1.09
(0.82,1.44)
0.57
After ﬁrst episode of febrile illness Crude‡ 914 0.64 (0.49,0.82) 1011 0.76 (0.63,0.93) 1.12
(0.81,1.54)
0.50
Adjusted† 1.13
(0.82,1.55)
0.47
Repeat malaria after ﬁrst episode of
febrile illness
Crude‡ 697 0.35 (0.26,0.47) 778 0.41 (0.32,0.52) 1.08
(0.74,1.59)
0.68
Adjusted† 1.09
(0.75,1.59)
0.64
Incidence of severe febrile illness
after ﬁrst episode of febrile illness
Crude‡ 321 0.51 (0.09,0.24) 371 0.17 (0.11,0.28) 1.11
(0.56,2.15)
0.78
Adjusted† 1.13
(0.58,2.21)
0.72
Incidence of moderate after ﬁrst
episode of febrile illness
Crude‡ 349 0.16 (0.13,0.21) 358 0.17 (0.14,0.21) 1.02
(0.73,1.43)
0.91
Adjusted† 1.04
(0.76,1.44)
0.80
Incidence of severe anaemia after
ﬁrst episode of febrile illness
Crude‡ 266 0.11 (0.09,0.14) 279 0.11 (0.95,0.15) 1.05
(0.78,1.44)
0.74
Adjusted† 1.04
(0.76,1.41)
0.82
‡ Crude estimates account for cluster-randomised design.
†Adjusted for cluster-randomised design and other covariates.
doi:10.1371/journal.pone.0152960.t003
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Fig 2. Survival curve of time to malaria after the first episode of a febrile illness in a) 1st or only episode of malaria b) all episodes of malaria.
doi:10.1371/journal.pone.0152960.g002
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malaria however, none of the above-mentioned studies had an appropriate comparator arm
and there was no random allocation to either test-based or clinical judgement-based treatment.
This main finding of this study is that mRDT-based treatment of febrile illness in<5 year
old children did not result in an increase in the incidence of malaria, anaemia, severe febrile ill-
nesses or the use of antibiotics in this high-transmission setting. These findings ran counter to
our expectation that the test-based approach would deny a high proportion of children the pro-
phylactic benefit that OPT offers in children whose fever is non-malarial.[15] The likely
explanatory factors for this are the high background level of malaria transmission (blood smear
positivity was 50.3% and 53.3% in RDT and CJ arms respectively) and the low RDT specificity
(due to HRP-2 antigen persistence) which resulted in a high proportion of children in both
arms being given ACT. The rather modest difference of 9% in the rate of ACT use between the
two arms in this study is similar to the 14% observed in a similarly high-transmission setting in
Burkina Faso.[22] It is however markedly lower than the 50% and 67% recorded in low-trans-
mission settings in Zanzibar and north-eastern Tanzania respectively.[23,24]
Another factor that could explain the lack of significant effect on the risk of malaria was the
significant difference in the proportion of children who were blood smear positive but did not
receive ACT. This occurred more among children in the CJ-arm than among children in the
RDT-arm (12.5% vs. 6.5%; p = 0.04). Given that previous studies have established that the
strongest predictor of a repeat episode of malaria is an index episode of parasitaemia,[25,26]
the higher false-negative diagnosis of parasitaemic children in the clinical judgement arm
could have contributed to an increased risk of malaria in children in this group.
Reduction in ACT use
An important factor that motivates the roll-out of test-based management of malaria is the
expectation that it will lead to massive reduction in the wasteful use of ACTs.[5,6,24] The
rather modest 9% reduction in ACT use observed in this study therefore raises concern about
whether the expectation of massive reduction in ACT use could justify investments in the roll
out of test-based management of malaria in high-transmission settings. This modest reduction
was achieved in a rigorously-managed setting. In real-life settings where health worker adher-
ence to RDT-negative results is unlikely to be optimal, the reduction in ACT use is likely to be
even less. The contrast in extents of reduction in ACT use between high and low malaria trans-
mission settings has been alluded to earlier. A cost-benefit analysis that included health worker
adherence to test-results has also pointed to the fact that it might not be beneficial to imple-
ment test-based management of malaria in high-transmission settings (assuming reduction in
ACT use is a major consideration) and the presumptive approach might be a more appropriate
approach.[27] The expectation that test-based management of malaria will lead to massive
reduction in ACT use cannot be strong enough basis to argue for its use.
Quality of care and antibiotic use
An important finding in this study is the fact that compared with children in the RDT arm, a
significantly higher number of smear positive children in the CJ arm did not receive ACT. This
finding suggest that the presumptive approach is not an efficient means for reaching children
who are parasitaemic and need to be given ACTs. Conversely the use of RDT significantly
improves the targeting to ACTs to malaria cases. On this basis, the test-based approach can be
said to lead to improvement in the quality of care.
In this study we found the use of HRP-2 RDT to have a PPV of 64%. This implies that possi-
bly one in every three RDT positive cases could actually be blood smear negative and is RDT
positive, likely on account of the persistence of HRP-2 antigens. This findings has implications
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for the training of clinicians on the interpretation of RDT results, the need for proper history-
taking in the assessment of children and caution against over-reliance on RDT result to form
the basis of the diagnosis of clinical malaria. There is also the need for caution in interpreting
these findings to suggest a need for antibiotics in all cases where RDT result is positive but
blood smear result is negative. In earlier work in the same study area, the positive yield on
blood culture among RDT negative under-five children was less than 12%.[18]
A major concern about the shift to test-based approach has been the prospect that it could
increase inappropriate use of antibiotics.29-33 The basis of the concern is that restricting ACT
to confirmed malaria cases will increase the number of cases subsequently classified as non-
malarial febrile illnesses, and in the absence of appropriate diagnostic tools these cases will be
presumptively treated with antibiotics. In this study we found that prescription of antibiotics
only or in combination with ACT was lower in the RDT arm compared to the CJ arm. How-
ever, the proportion of children treated with an antibiotic use was highest (85%) among chil-
dren in the RDT arm who were RDT-negative. This compares with 44% among children in the
RDT arm who tested positive, 51% and 62% among children in the CJ arm who (as later deter-
mined) were blood smear positive and negative respectively. The high antibiotic use in the
RDT negative children did not however translate into overall significant increase in antibiotic
use in the RDT arm (actually was reduced) because it was offset by reduction in use (44%) in
children who had malaria and got confirmed with RDT. The relatively high background
malaria prevalence implied that this reduction was large enough to offset the increased use in
the RDT negative group. Our data suggests that the result of RDT (either positive or negative)
will influence the decisions of health workers whether to use antibiotics or not. However, in
high malaria transmission settings the reduction in antibiotic use in RDT-positive children
would result in overall reduction in antibiotic use.
The pattern in antibiotic use and reduction in ACT use, without adverse effect on treatment
outcomes suggest that test-based management of malaria improved the quality of care of both
malaria and non-malaria febrile illnesses in this high transmission setting. The findings never-
theless add to available evidence on the need for further work to identify how best to target
antibiotics use in the management of childhood febrile illnesses
The extrapolation of these findings to program settings is limited by a number of opera-
tional considerations. The level of provider adherence to test based management of malaria
observed in this study was very high, good quality mRDT stored in optimum conditions, and
the study children were closely monitored. Thus any deterioration in their clinical condition
resulting from inadequate treatment was promptly identified and the caregivers brought the
children for review as recommended. On the contrary, in routine health systems, the follow up
of children is often not optimal, caregivers may not return for reviews, and the accuracy of
mRDT may be variable.
Conclusion
The application of test-based management of malaria did not increase the risk of malaria or
anaemia in children in this setting. It improves the quality of care. It however did not lead to
massive reduction in ACT use. The WHO recommendation of test-based management of
malaria in children is justified in this setting.
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